Evidence map›Paper›PMID 34459497›Full record

ArticleActa neurologica Scandinavica2021

An Internet-based study on the impact of COVID-19 pandemic-related lockdown on migraine in India.

Debashish Chowdhury, Anand Krishnan, Ashish Duggal, Debabrata Datta, Ankit Mundra, Vaibhav Deorari, Apoorva Tomar, Arun Koul

Abstract read
In one paragraph

Article in Acta neurologica Scandinavica, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Debashish ChowdhuryNeurology, GB Pant Institute of Post Graduate Medical Education and Research, New Delhi, India.ORCID https://orcid.org/0000-0002-0293-5438
Anand KrishnanCommunity Medicine, All India Institute of Medical Sciences, New Delhi, India.
Ashish DuggalNeurology, GB Pant Institute of Post Graduate Medical Education and Research, New Delhi, India.
Debabrata DattaNeurology, GB Pant Institute of Post Graduate Medical Education and Research, New Delhi, India.
Ankit MundraNeurology, GB Pant Institute of Post Graduate Medical Education and Research, New Delhi, India.
Vaibhav DeorariNeurology, GB Pant Institute of Post Graduate Medical Education and Research, New Delhi, India.
Apoorva TomarNeurology, GB Pant Institute of Post Graduate Medical Education and Research, New Delhi, India.
Arun KoulNeurology, GB Pant Institute of Post Graduate Medical Education and Research, New Delhi, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo assess the impact of lockdown during the COVID-19 pandemic on migraine patients in India on disease activity, healthcare accessibility, and quality of life (QoL). MATERIALS &

methodsThis internet-based survey study using a structured questionnaire was conducted from 27th April to 31st July 2020. Previous physician-diagnosed migraine patients or those fulfilling any two of three clinical features (limitation of activities for >1 day, associated nausea or vomiting, and photophobia or phonophobia) were diagnosed as migraine patients. QoL was captured using a Likert scale and determinants of poor QoL were identified by logistic regression.

resultsA total of 4078 persons completed the full survey out of which 984 (24.1%) had migraine (mean age 35.3 ±11.2). Compared to pre-lockdown, 51.3% of migraineurs reported worsening of their headaches in terms of increased attack frequency (95.6%), increased headache days (95%), increased attack duration (89.9%) and increased headache severity (88.1%). The worsening was attributed to anxiety due to the pandemic (79.7%), inability or difficulty to access healthcare (48.4%) and migraine medicines (48.9%), and financial worries (60.9%). 26.8% of migraineurs reported poor QoL compared to 7.37% of non-migraineurs [p<0.0001]. Migraine affected QoL in 61.4% of migraineurs. The predictors of poor QoL on logistic regression included worsening migraine during the lockdown (AOR 4.150; CI 2.704- 6.369) and difficulty accessing migraine medicines (AOR 4.549; CI 3.041- 6.805). Employment as an essential COVID-19 worker (AOR 0.623; CI 0.409- 0.950) protected against poor QoL.

conclusionsCOVID-19 pandemic-related lockdown greatly impacted migraine patients in India which significantly reduced their QoL.

Indexed as

COVID-19Migraine DisordersAdultCommunicable Disease ControlHumansIndiaInternetMiddle AgedPandemicsQuality of LifeSARS-CoV-2Young Adultaccess to health careCOVID-19lockdownmigrainepreventive treatmentquality of life

Identifiers

PMID34459497
PMCPMC8652819

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.